drugset
Drugs / Human Allogenic Umbilical Cord Mesenchymal Stromal Cells
last change Oct 2025 re-read 3 minutes ago

Human Allogenic Umbilical Cord Mesenchymal Stromal Cells

Cell therapy

Developed for
bronchopulmonary dysplasia
Investigated by
Canadian Institutes of Health Research (CIHR) · Ottawa Hospital Research Institute · Stem Cell Network

Trials 1

today NCT07058025 · Ph 2
202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT07058025 Oct 2025 → Sep 2028 expected bronchopulmonary dysplasia Ottawa Hospital Research Institute Not yet recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human Allogenic Umbilical Cord Mesenchymal Stromal Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT07058025 ↗
Modality Cell therapy “Cell therapy” NCT07058025 ↗
Route Intravenous “Route of administration: IV infusion on peripheral intravenous catheter.” NCT07058025 ↗